Oral candidiasis |
|
Increased Sap activity occurred in C. albicans strains isolated from HIV-positive patients with oral candidiasis compared with HIV-negative C. albicans carriers |
46, 252
|
C. albicans from HIV-positive patients with oropharyngeal candidiasis produced more proteinase activity than did C. albicans from HIV-negative asymptomatic oral carriers or HIV-negative subjects with oral candidiasis. |
166 |
Vaginal candidiasis |
|
C. albicans isolates from patients with vaginal candidiasis were significantly more proteolytic than isolates from asymptomatic vaginal carriers. |
4, 28, 43
|
C. albicans isolates from HIV-positive women with vaginitis produced significantly higher levels of Sap than did C. albicans strains isolated from HIV-positive asymptomatic carriers or HIV-negative subjects with candidal vaginitis. |
49 |
Animal models |
|
High-Sap-producing oral and vaginal C. albicans strains from HIV-positive patients were more pathogenic in the mouse and rat vaginitis models than were lower-Sap-producing C. albicans strains from HIV-negative patients. |
48, 49
|
There was a correlation between C. albicans adherence to buccal epithelial cells, proteinase production, and lethality in mice. Higher-Sap-producing strains showed higher levels of tissue colonization in the liver, kidneys, and spleen |
2 |
Other diseases |
|
There was no difference in Sap production from oral C. albicans isolated from patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and healthy controls |
87 |
Production of Sap did not differ between patients with antibiotic-associated diarrhea and control subjects. |
118 |
Higher levels of Sap were produced by C. albicans from children with acute diarrhea than those with chronic diarrhea, which may account for the more severe symptoms. |
136 |